B6-responsive disorders: A model of vitamin dependency

Journal of Inherited Metabolic Disease

Volumn 29, Issue 2-3, 2006, Pages 317-326

  Clayton, Peter T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ALKALINE PHOSPHATASE; CARBIDOPA; CHAPERONE; CYCLOSERINE; CYSTATHIONINE BETA SYNTHASE; HYDRALAZINE; ISONIAZID; ORNITHINE OXOACID AMINOTRANSFERASE; PENICILLAMINE; PYRIDOXAL; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; PYRROLINE 5 CARBOXYLATE REDUCTASE; VITAMIN B COMPLEX;

ARTICLE; DIETARY INTAKE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG STRUCTURE; EPILEPSY; HOMOCYSTINURIA; HUMAN; HYPERPROLINEMIA; HYPERVITAMINOSIS; HYPOPHOSPHATASIA; INBORN ERROR OF METABOLISM; LIVER TOXICITY; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY; PYRIDOXINE DEFICIENCY; SEIZURE; STRUCTURE ANALYSIS; TUBERCULOSIS; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; WILSON DISEASE; X LINKED SIDEROBLASTIC ANEMIA; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG INTERACTION; METABOLISM; REVIEW;

DIETARY SUPPLEMENTS; DRUG INTERACTIONS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METABOLISM, INBORN ERRORS; PYRIDOXAL PHOSPHATE; PYRIDOXINE; VITAMIN B 6; VITAMIN B 6 DEFICIENCY; VITAMIN B COMPLEX;

EID: 33745083423     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-005-0243-2     Document Type: Article

References (63)

1. An SJ, Park SK, Hwang IK, et al (2004) Vigabatrin inhibits pyridoxine-5′-phosphate oxidase, not pyridoxal kinase in the hippocampus of seizure prone gerbils. Neurochem Int 44: 133-137.
2. Aoki Y, Muranaka S, Nakabayashi K, Ueda Y (1979) delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease. J Clin Invest 64: 1196-1203.
3. Apeland T, Mansoor MA, Pentieva K, McNulty H, Seljeflot I, Strandjord RE (2002) The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs. Epilepsy Res 51: 237-247.
4. Barber GW, Spaeth GL (1969) The successful treatment of homocystinuria with pyridoxine. J Pediatr 75: 463-478.
5. Baxter P (2001) Pyridoxine dependent/responsive seizures. In: Baxter P, ed. Vitamin Responsive Conditions in Paediatric Neurology. London: MacKeith Press, 109-165.
6. Been JV, Bok LA, Andriessen P, Renier WO (2005) Epidemiology of pyridoxine-dependent seizures in The Netherlands. Arch Dis Child 90: 1293-1296.
7. 6. Br J Nutr 81: 7-20.
8. Berson EL, Schmidt SY, Shih VE (1978) Ocular and biochemical abnormalities in gyrate atrophy of the choroid and retina. Ophthalmology 85: 1018-1027.
9. Berson EL, Shih VE, Sullivan PL (1981) Ocular findings in patients with gyrate atrophy on pyridoxine and low-protein, low-arginine diets. Ophthalmology 88: 311-315.
10. Biehl JP, Vilter RW (1954) Effects of isoniazid on pyridoxine metabolism. J Am Med Assoc 156: 1549-1552.
11. 6 (pyridoxine) and its derivatives are efficient singlet oxygen quenchers and potential fungal antioxidants. Photochem Photobiol 71: 129-134.
12. Cormier-Daire V, Dagoneau N, Nabbout R, et al (2000) A gene for pyridoxine-dependent epilepsy maps to chromosome 5q31. Am J Hum Genet 67: 991-993.
13. Cotter PD, May A, Fitzsimons EJ, et al (1995) Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts. J Clin Invest 96: 2090-2096.
14. Coursin DB (1954) Convulsive seizures in infants with pyridoxine-deficient diet. J Am Med Assoc 154: 406-408.
15. Dalton K, Dalton MJ (1987) Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurol Scand 76: 8-11.
16. Ebinger M, Schultze C, Konig S (1999) Demographics and diagnosis of pyridoxine-dependent seizures. J Pediatr 134: 795-796.
17. 6 synthesis. Proc Natl Acad Sci USA 96: 9374-9378.
18. Eliot AC, Kirsch JF (2004) Pyridoxal phosphate enzymes: Mechanistic, structural and evolutionary considerations. Annu Rev Biochem 73: 383-415.
19. Erlandsen H, Pey AP, Gámez A, et al (2004) Correction of kinetic and stability defects by terahydrobiopterin in phenylketonuria with certain phenylalanine hydroxylase mutations. Proc Natl Acad Sci USA 101: 16903-16908.
20. 6 deficiency and seizures in hyperprolinemia type II. J Biol Chem 276: 15107-15116.
21. Fouts PJ, Lepkovsky S (1942) A green pigment-producing compound in urine of pyridoxine-deficient dogs. Proc Soc Exp Biol Med 50: 221-222.
22. Furuyama K, Fujita H, Nagai T, et al (1997) Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene. Blood 90: 822-830.
23. Glenn GM, Krober MS, Kelly P, McCarty J, Weir M (1995) Pyridoxine as therapy in theophylline-induced seizures. Vet Hum Toxicol 37: 342-345.
24. Greengard O, Gordon M (1963) The cofactor-mediated regulation of apoenzyme levels in animal tissues. I. The pyridoxine-induced rise of rat liver tyrosine transaminase level in vivo. J Biol Chem 238: 3708-3710.
25. Gross-Mesilaty S, Hargrove JL, Ciechanover A (1997) Degradation of tyrosine aminotransferase (TAT) via the ubiquitin-proteasome pathway. FEBS Lett 405: 175-180.
26. Hallert C, Grant C, Grehn S, et al (2002) Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years. Aliment Pharmacol Ther 16: 1333-1339.
27. 6. Eur J Paediatr Neurol 2: 319-322.
28. Hunt AD Jr, Stokes J Jr, McCrory WW, Stroud HH (1954) Pyridoxine dependency: Report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics 13: 140-145.
29. Iqbal SJ, Brain A, Reynolds TM, Penny M, Holland S (1998) Relationship between serum alkaline phosphatase and pyridoxal-5′-phosphate levels in hypophosphatasia. Clin Sci (Lond) 94: 203-206.
30. 6. Am J Hum Genet 32: 529-541.
31. 6. J Clin Invest 43: 894-903.
32. Kretsch MJ, Sauberlich HE, Newbrun E (1991) Electroencephalographic changes and periodontal status during short-term vitamin B-6 depletion of young, nonpregnant women. Am J Clin Nutr 53: 1266-1274.
33. Lee P, Kuhl W, Gelbart T, et al (1994) Homology between a human protein and a protein of the green garden pea. Genomics 21: 371-378.
34. 6) neurotoxicity: Enhancement by protein-deficient diet. J Appl Toxicol 24: 497-500.
35. Litmanovitz I, Reish O, Dolfin T, et al (2002) Glu274Lys/Gly309Arg mutation of the tissue-nonspecific alkaline phosphatase gene in neonatal hypophosphatasia associated with convulsions. J Inherit Metab Dis 25: 35-40.
36. Mackey AD, Lieu SO, Carman C, Gregory JF (2003) Hydrolytic activity towards pyridoxine-5-β-d-glucoside in rat intestinal mucosa is not increased by vitamin B-6 deficiency: Effect of basal diet composition and pyridoxine intake. J Nutr 133: 1362-1367.
37. McCormick DB, Snell EE (1961) Pyridoxal phosphokinases. II. Effects of inhibitors. J Biol Chem 236: 2085-2088.
38. McKinley MC, McNulty H, McPartlin J, et al (2001) Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr 73: 759-764.
39. Mills PB, Surtees RAH, Champion MP, et al (2005) Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate oxidase. Hum Mol Genet 14: 1077-1086.
40. Mills PB, Struys E, Jakobs C, et al (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nature Medicine 12: 307-309.
41. 6 status. J Chromatogr 337: 249-258.
42. Mudd SH, Levy HL, Kraus JP (2001) Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2007-2056.
43. Namazi MR (2003) Pyridoxal 5′-phosphate as a novel weapon against autoimmunity and transplant rejection. FASEB J 17: 2184-2186.
44. 6 depletion in man on the plasma concentration and the urinary excretion of free amino acids. J Nutr 101: 185-191.
45. Perez-Llarena, FJ, Rodriguez-Garcia A, Enguita FJ, et al (1998) The pcd gene encoding piperideine 6-carboxylate dehydrogenase involved in biosynthesis of alpha-aminoadipic acid is located in the cephamycin cluster of Streptomyces clavuligerus. J Bacteriol 180: 4753-4756.
46. Plecko B, Stockler-Ipsiroglu S, Paschke E, Erwa W, Struys EA, Jakobs C (2000) Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol 48: 121-125.
47. Rathbun JC (1948) Hypophosphatasia: A new developmental anomaly. Am J Dis Child 75: 822-831.
48. Salazar P, Tapia R (2001) Seizures induced by intracerebral injection of pyridoxal-5′-phosphate: Effect of GABAergic drugs and glutamate receptor antagonists. Neuropharmacology 41: 546-553.
49. Salhany JM, Schopfer LM (1993) Pyridoxal 5′-phosphate binds specifically to soluble CD4 protein, the HIV-1 receptor. J Biol Chem 268: 7643-7645.
50. Sauberlich HE (1999) Vitamin B-6 (pyridoxine). In: Sauberlich HE, ed. Laboratory Tests for the Assessment of Nutritional Status, 2nd ed. Boca Raton: CRC Press, 71-102.
51. Skvorak AB, Robertson NG, Yin Y, et al (1997) An ancient conserved gene expressed in the human inner ear: Identification, expression analysis, and chromosomal mapping of human and mouse antiquitin (ATQ1). Genomics 46: 191-199.
52. Takagi M, Fukui T, Shimomura S (1982) Catalytic mechanism of glycogen phosphorylase: Pyridoxal(5′)diphospho(1)-α-d-glucose as a transition-state analogue. Proc Natl Acad Sci USA 79: 3716-3719.
53. 6. FASEB J 8: 343-349.
54. Ubbink JB, Bissbort S, Vermaak WJ, Delport R (1990a) Inhibition of pyridoxal kinase by methylxanthines. Enzyme 43: 72-79.
55. Ubbink JB, Delport R, Bissbort S, Vermaak WJ, Becker PJ (1990b) Relationship between vitamin B-6 status and elevated pyridoxal kinase levels induced by theophylline therapy in humans. J Nutr 120: 1352-1359.
56. Veresova S, Kabova R, Velisek L (1998) Proconvulsant effects induced by pyridoxine in young rats. Epilepsy Res 29: 259-264.
57. Walker V, Mills GA, Peters SA, Merton WL (2000) Fits, pyridoxine, and hyperprolinaemia type II. Arch Dis Child 82: 236-237.
58. Wang HS, Kuo MF, Chou ML, et al (2005) Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy. Arch Dis Child 90(5): 512-515.
59. Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP, MacGregor GR (1995) Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nature Genetics 11: 45-51.
60. 6 in management of gyrate atrophy of the choroids and retina. Lancet 2: 1213.
61. 6 for gyrate atrophy of the choroid and retina. Ophthalmology 88: 316-324.
62. 6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5′-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase. J Clin Invest 81: 1234-1239.
63. Yoshida I, Sakaguchi Y, Nakano M, Yamashita F, Hitoshi T (1985) Pyridoxal phosphate-induced liver injury in a patient with homocystinuria. J Inherit Metab Dis 8: 91.